『Hyperlipidemia treatment ‘Atrovan Tablet 20mg’ launched』

 

KyungDong Pharm Co., Ltd. will release 『Atroban Tablet 20mg』, a statin-based hyperlipidemia treatment, on June 1. 『Atroban Tablet 20mg』 is a product released by doubling the content of Atorvastatin, the ingredient in ‘Atroban Tablet’, the current flagship product of KyungDong Pharm Co., Ltd., to 20mg.

Atorvastatin is the most prescribed ingredient not only in the statin class but also in overall hyperlipidemia treatment (lipid-lowering drugs). Statin-type drugs not only have an excellent LDL-C lowering effect compared to other treatments, but also simultaneously reduce neutral fat levels and increase HDL-C levels, making them very effective in treating overall hyperlipidemia (dyslipidemia). In particular, Atorvastatin preparations are known to have the greatest lipid-lowering effect at the same dose compared to the same statin preparations, and unlike other ingredients that must be taken mainly in the evening, drug compliance is known to be very good even when taken at any time of the day regardless of time.

The newly launched 『Atrovan Tablet 20mg』 and the existing Atorvastatin Tablet (Atorvastatin 10mg) are expected to once again drive overall sales in the future and serve as a stepping stone for further growth.

 

 

☆ Product Information ☆

 

1. Product name: Atroban tablet 20mg

2. Ingredient content: Atorvastatin 20mg (Atorvastatin 20mg)

3. Efficacy: Reduction of risk of cardiovascular disease, dietary supplement for patients with primary hypercholesterolemia and combined dyslipidemia, dietary supplement for pediatric patients aged 10 to 17 years with hypercholesterolemia, etc.

4. Dosage: 1 time per day, 10~80mg per time

5. Packaging unit; 30 tablets, 100 tablets

6. Product code: 648103260

 

※ For other details, please refer to the product manual.